Evidence mapPaperPMID 42428225Full record

ArticleCureus2026

Association of Systemic Inflammatory Indices With Breast Cancer: A Cross-Sectional Analysis of National Health and Nutrition Examination Survey (NHANES) Data.

Aqsa Kiran, Haseeb Nasir, Sarmad Shaikh, Elsa Zainab Ansari, Aimen Luqman, Ayesha Urooj

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aqsa KiranPublic Health, Anglia Ruskin University, Chelmsford, GBR.
Haseeb NasirInternal Medicine, Military Hospital, Rawalpindi, PAK.
Sarmad ShaikhGeneral Surgery, Jinnah Postgraduate Medical Centre (JPMC), Karachi, PAK.
Elsa Zainab AnsariInternal Medicine, Southampton General Hospital NHS Foundation Trust, Southampton, GBR.
Aimen LuqmanDiagnostic Radiology, Combined Military Hospital, Multan, PAK.
Ayesha UroojInternal Medicine, People's Primary Healthcare Initiative (PPHI) Sindh, Thatta, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer remains one of the leading causes of cancer-related morbidity and mortality among women worldwide. Systemic inflammatory indices derived from routine hematological parameters, including NLR, PLR, and SII, have recently gained attention as potential biomarkers associated with breast cancer risk and progression. However, population-based evidence evaluating these inflammatory markers after adjustment for demographic, socioeconomic, and lifestyle-related confounders remains limited.

aimWe evaluated the association of systemic inflammatory indices, including NLR, PLR, and SII, with self-reported history of breast cancer in a nationally representative cross-sectional population sample after adjustment for demographic, socioeconomic, and lifestyle-related factors.

methodsThis cross-sectional analytical study utilized data from the NHANES 2021-2023 cycle. Female participants aged ≥18 years with available complete blood count parameters and breast cancer status information were included. Breast cancer status was defined using self-reported physician diagnosis. NLR, PLR, and SII were calculated from hematological parameters obtained through standardized laboratory assessment. Demographic, socioeconomic, and lifestyle variables included age, body mass index (BMI), race/ethnicity, poverty-income ratio (PIR), smoking history, and alcohol intake. Due to non-normal distribution, continuous variables were summarized as median (interquartile range) and compared using Mann-Whitney U tests. Categorical variables were analyzed using Rao-Scott adjusted chi-square tests accounting for the NHANES complex survey design. Multivariable survey-weighted logistic regression models were constructed separately for NLR, PLR, and SII, adjusting for potential confounders. Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were reported, and p < 0.05 was considered statistically significant.

resultsA total of 5,298 women were included, of whom 150 (weighted prevalence ~1.9%) reported a history of breast cancer. Women with breast cancer were older than those without breast cancer. Exploratory unweighted descriptive comparisons showed higher median NLR, PLR, and SII values among participants with breast cancer compared with controls. However, after adjustment for demographic, socioeconomic, and lifestyle factors in survey-weighted multivariable models, none of the inflammatory indices demonstrated an independent association with breast cancer. Age consistently remained the strongest independent predictor of breast cancer across all models (p < 0.001).

conclusionAlthough exploratory unweighted analyses demonstrated higher inflammatory index values among women with breast cancer, these associations were not independently significant in survey-weighted multivariable models.

Indexed as

breast neoplasmsinflammationsleukocyteneutrophilplatelet counts

Identifiers

PMID42428225
PMCPMC13347244

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.